Swiss National Bank Decreases Holdings in Hologic, Inc. $HOLX

Swiss National Bank lowered its position in Hologic, Inc. (NASDAQ:HOLX) by 5.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 642,340 shares of the medical equipment provider’s stock after selling 36,900 shares during the period. Swiss National Bank owned approximately 0.29% of Hologic worth $43,352,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. The Manufacturers Life Insurance Company grew its holdings in Hologic by 294.3% in the second quarter. The Manufacturers Life Insurance Company now owns 11,022,455 shares of the medical equipment provider’s stock valued at $718,223,000 after purchasing an additional 8,227,318 shares during the last quarter. Invesco Ltd. raised its stake in shares of Hologic by 72.5% during the 2nd quarter. Invesco Ltd. now owns 8,340,785 shares of the medical equipment provider’s stock worth $543,486,000 after buying an additional 3,505,828 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Hologic by 1.7% during the 2nd quarter. Geode Capital Management LLC now owns 5,828,325 shares of the medical equipment provider’s stock worth $378,209,000 after buying an additional 97,142 shares during the last quarter. Black Creek Investment Management Inc. boosted its position in shares of Hologic by 26.1% in the 2nd quarter. Black Creek Investment Management Inc. now owns 4,027,829 shares of the medical equipment provider’s stock worth $262,453,000 after buying an additional 832,444 shares in the last quarter. Finally, Bank of America Corp DE boosted its position in shares of Hologic by 2.2% in the 2nd quarter. Bank of America Corp DE now owns 3,090,306 shares of the medical equipment provider’s stock worth $201,364,000 after buying an additional 66,453 shares in the last quarter. 94.73% of the stock is owned by hedge funds and other institutional investors.

Hologic Trading Down 0.2%

Hologic stock opened at $75.22 on Friday. The stock has a market cap of $16.79 billion, a PE ratio of 31.34, a P/E/G ratio of 2.24 and a beta of 0.73. The stock has a 50-day moving average price of $75.12 and a 200 day moving average price of $72.58. Hologic, Inc. has a 52 week low of $51.90 and a 52 week high of $75.75. The company has a current ratio of 4.04, a quick ratio of 3.32 and a debt-to-equity ratio of 0.48.

Hologic (NASDAQ:HOLX) last released its earnings results on Thursday, January 29th. The medical equipment provider reported $1.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.09 by ($0.05). Hologic had a net margin of 13.18% and a return on equity of 19.58%. The firm had revenue of $1.05 billion during the quarter, compared to analysts’ expectations of $1.07 billion. During the same quarter last year, the company posted $0.87 earnings per share. Hologic’s revenue for the quarter was up 2.5% on a year-over-year basis. Equities research analysts predict that Hologic, Inc. will post 4.28 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the stock. Evercore downgraded shares of Hologic from an “outperform” rating to an “in-line” rating and dropped their target price for the company from $79.00 to $78.00 in a report on Monday, January 5th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Hologic in a report on Wednesday, January 28th. Argus lowered shares of Hologic from a “buy” rating to a “hold” rating in a research report on Monday, January 12th. Finally, BNP Paribas Exane cut shares of Hologic from a “strong-buy” rating to a “hold” rating and set a $79.00 price objective for the company. in a research note on Friday, November 21st. Two research analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $78.42.

About Hologic

Hologic, Inc (NASDAQ: HOLX) is a global medical technology company specializing in women’s health. Headquartered in Marlborough, Massachusetts, the company develops and manufactures diagnostic products, imaging systems and surgical solutions designed to detect, diagnose and treat diseases with a primary focus on breast and skeletal health, gynecological conditions and molecular diagnostics. Its product portfolio includes digital mammography systems, 3D mammography solutions, bone densitometry equipment and molecular assays for infectious disease and oncology applications.

Since its founding in 1985, Hologic has grown through both internal innovation and strategic acquisitions.